Sort
23,748 grants matching “melanoma”
Retroviral Replicating Vector-mediated Gene Therapy for Ovarian Cancer
$519,704Noriyuki Kasahara · University Of California, San Francisco · R01 · FY2022 · CA
Defining the role of mitochondrial injury in MEK inhibitor cardiotoxicity
$519,681Brian C Jensen · Univ Of North Carolina Chapel Hill · R01 · FY2025 · HL
Mouse Resource Core
$519,574Edward A Clark · University Of Washington · U19 · FY2017 · AI
Regulation of Ras-Dependent Signal Transduction Pathways
$519,504Deborah K Morrison · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN: A Phase II Clinical Trial in Adolescents/Young Adults (AYA)with CNS Malignancies
$519,480Lee Roy Morgan · Dekk-Tec, Inc. · R44 · FY2019 · CA
STING-Activating Polymeric Nanovaccines for T Cell Therapy of Melanoma
$519,464Jinming Gao · Ut Southwestern Medical Center · U01 · FY2019 · CA
Immunotherapeutic Nanoparticle Delivery to Melanoma With MR-Guided Focused Ultrasound
$519,263Richard J Price · University Of Virginia · R01 · FY2017 · CA
MITF from control of pigmentation to melanoma risk
$519,228David E Fisher · Massachusetts General Hospital · R01 · FY2024 · AR
Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms
$519,202Peggy Reynolds · University Of California, San Francisco · R01 · FY2020 · CA
A Convergent Node in Melanoma to Block Multiple Oncogenic Pathways Simultaneously
$519,100Lawrence Kwong · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
Generation of T-cell receptors recognizing antigens on non-melanoma tumors
$518,832James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
CDKN2A couples lipid metabolism to ferroptosis in glioblastoma
$518,756David A. Nathanson · University Of California Los Angeles · R01 · FY2022 · NS
NCI National Clinical Trials Network â Network Lead Academic Participating Site
$518,725Lawrence E Flaherty · Wayne State University · UG1 · FY2022 · CA
Microbiota-Immune Interactions in CTLA-4 Antibody Blockade-Induced Colitis
$518,680Gabriel Nunez · University Of Michigan At Ann Arbor · R01 · FY2025 · DK
Targeting Hippo pathway in melanoma
$518,652Xu Wu · Massachusetts General Hospital · R01 · FY2022 · CA
Targeting Hippo pathway in melanoma
$518,652Xu Wu · Massachusetts General Hospital · R01 · FY2023 · CA
Harnessing NKT Cell Activation by Glycolipids
$518,569Amy R. Howell · University Of Connecticut Storrs · R01 · FY2021 · GM
HIGH-RESOLUTION IMAGING OF OCULAR MELANOMA AND RETINA
$518,503University Of California San Diego · R01 · FY2002 · EY
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$518,457Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$518,457Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Defining Mechanisms of Pathological Trans-Lesion Synthesis During Carcinogenesis
$518,457Cyrus Vaziri · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
$518,453Sheila H Ridner · Vanderbilt University · R01 · FY2010 · CA
Localized immunotherapy using alum-binding therapeutics
$518,397Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2023 · EB
Novel Targeted Combinatorial Therapy for Hepatocellular Carcinoma
$518,339Devanand Sarkar · Virginia Commonwealth University · R01 · FY2020 · CA
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
$518,165Nir Hacohen · Broad Institute, Inc. · R01 · FY2017 · CA